Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Medivir AB
Medivir AB
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Medivir partners with GVK BIO to optimise R&D
Company reorganises its discovery and research operations and focuses on key areas of oncology and infectious diseases
Research & Development
Medivir and Cancer Research Technology link up to develop new cancer drugs
Will conduct a two-year research programme to develop small molecules targeting the ADAM8 protein
Research & Development
Medivir makes changes to management team
To create a smaller and more effective team with fewer functions
Research & Development
Medivir to develop new drugs for bacterial infections
Swedish University of Agricultural Sciences will receive a fee for research services
Medivir hires head of commercial activities
Henric Juserius joins the Swedish firm in August
Research & Development
Medivir signs dengue virus deal with Janssen
Strengthens presence in infectious diseases
Research & Development
Medivir appoints vp for r&d projects
Charlotte Edenius takes up newly created position
Subscribe now